Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri

Cancer

Volumn 77, Issue 4, 1996, Pages 710-716

  Sanfilippo, Joseph S ^a   Miseljic, Slobodan ^a   Yang, Ai Ru ^a   Doering, David L ^a   Shaheen, Raymond M ^a   Wittliff, James L ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

cathepsin D; EGF receptors; endometrial carcinoma; HER 2 neu oncoprotein; prognostic factors; uterus

Indexed keywords

CATHEPSIN D; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ARTICLE; BIOPSY; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENDOMETRIUM CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; LIGAND BINDING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

CATHEPSIN D; CELL MEMBRANE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; LEIOMYOMA; PROGNOSIS; RADIOIMMUNOASSAY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; UTERINE NEOPLASMS; UTERUS;

EID: 0030020549     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960215)77:4<710::AID-CNCR17>3.0.CO;2-3     Document Type: Article

References (38)

1. Di Saia PJ, Creasman WT. Adenocarcinoma of the uterus. In: Di Saia PJ, Creasman WT, editors. Clinical Gynecologic Oncology. 4th edition. St. Louis: Mosby Year Book, 1993:156-93.
2. Wittliff JL, Pasic R, Bland KI. Steroid and peptide hormone receptors identified in breast tissue. In: Bland KI, Copeland EM III, editors. The Breast: comprehensive Management of Benign and Malignant Diseases. Philadelphia: WB Saunders, 1990:900-36.
3. Wittliff JL. Hormone and growth factor receptors. In: Donegan WL, Spratt JS, editors. Cancer of the Breast. 4th edition. Philadelphia: WB Saunders, 1995:346-74.
4. Hetzel DJ, Wilson TO, Keeny GL, Roche PC, Cha SS, Podratz KC. HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol 1992;47:179-85.
5. Khalifa MA, Abdoh AA, Mannel RS, Haraway SD, Walker J, Min K-W. Prognostic utility of epidermal factor receptor overexpression in endometrial adenocarcinomas. Cancer 1994;73:330-6.
6. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979;48:193-216.
7. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987; 56:881-914.
8. Goustin AS, Leof EB, Shiplay GD, Moses HL. Growth factors and cancer. Cancer Res 1986;46:1015-29.
9. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, et al. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 1986;319:230-4.
10. Schechter A, Hung M-C, Vaidyanathan L, Weinberg R, Yang-Feng T, Francke U, et al. The neu gene: an erb B-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 1985;229:976-83.
11. Lupu R, Colomer R, Zugmaier G, Sarup J, Shepard M, Slamon D, et al. Direct interaction of a ligand for the erb B-2 oncogene product with the EGF receptor and p185erbB2. Science 1990;249:1552-5.
12. Lupu R, Dickson RB, Lippman ME. The role of erb B-2 and its ligands in growth control of malignant breast epithelium. J Steroid Biochem Mol Biol 1992,43:229-36.
13. Barrett AJ. Cellular proteolysis. An overview. Ann N Y Acad Sci 1992;674:1-15.
14. Rochefort H, Cavailles V, Augereau P, Capony F, Maudelonde T, Tonitou I, et al. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem Mol Biol 1989;34:177-82.
15. Derynck R, Roberts AB, Winkler ME, Chen EY, Goenddel DV. Human transforming growth factor alpha: precursor structure and expression in E. coli. Cell 1984;38:287-93.
16. Sainsbury JRC, Farndon IR, Needham GK, Malcolm AJ, Harris AL. Epidermal growth factor receptor status as a predictor of early recurrence of and death from breast cancer, Lancet 1987;1:1398-402.
17. Salmon J, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-81.
18. Thorpe SM, Rochefort M, Garcia M, Freiss G, Christensen IJ, Khalaf MA, et al. Association between high concentrations of 52 cathepsin D and poor prognosis in primary breast cancer. Cancer Res 1989;49:6008-14.
19. Bigsby RM, Aixin L, Bomalaski J, Stehman FB, Look KY, Sutton GP. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium. Obstet Gynecol 1992;79(1):95-100.
20. Khalifa MA, Mannel RS, Haraway SD, Walker J, Min K-W. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol Oncol 1994;53:84-92.
21. Pasic R, Djulbegovic B, Wittliff JL. Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding. J Clin Lab Anal 1990;4:430-6.
22. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-59.
23. 6] luteinizing hormone releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. J Clin Lab Anal 1989;3:137-47.
24. Wittliff JL, Miseljic S, Peace SE, Offutt M, Lee BSF, Wittliff TH. A quality assurance program for new prognostic factors in breast cancer, Clin Chem 1994;40(6):1003.
25. 125I epidermal growth factor in human uterus. Cell Tissue Res 1986;246:543-8.
26. Hofmann GE, Rao CV, Barrows GH, Schultz GS, Sanfilippo JS. Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J Clin Endocrinol Metab 1984;58:380-4.
27. Smith K, Lejeune S, Harris AH, Rees MC. Epidermal growth factor receptors in human uterine tissues. Hum Reprod 1991;6(5):619-22.
28. Fitzpatrick SLD, Brightwell J, Wittliff JL, Barrows GH, Schultze GS. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progesterone receptor levels. Cancer Res 1984;44:3448-53.
29. Klign JGM, Berns PMJJ, Schmitz PIM, Foekens JA. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review of 5,232 patients. Endocr Rev 1992;13:3-17.
30. 6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res 1990;50:1841-6.
31. Wang D, Konishi I, Koshiyama M, Nanbu Y, Iwai T, Nonogaki H, et al. Immunohistochemical localization of c-erb B-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cyst, and common epithelial tumours of the ovary. Virchows Archiv A Pathol Anat Histopathol 1992;421:393-400.
32. Mileo AM, Fanuele M, Battaglia F, Scambia G, Benedetti-Panici G, Mattei E, et al. Preliminary evaluation of HER-2/ neu oncogene and epidermal growth factor receptors expression in normal and neoplastic human ovaries. Int J Biol Markers 1992;7(1):47-51.
33. Wang D, Konishi I, Koshiyama M, Mandai M, Nanbu Y, Ishikawa Y, et al. Expression of c-erbB-2 protein and epidermal growth factor receptor in endometrial carcinomas. Cancer 1993;72(9):2628-37.
34. Miseljic S, Yang AR, Cline VJM, Wittliff JL. Expression of epidermal growth factor receptors in human breast cancer: mass versus ligand binding capacity. Breast J 1995;1(2):102-6.
35. Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL, et al. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 1991;164(1):15-21.
36. Maudelonde T, Martinez P, Brouillet J-P, Laffargue F, Pages A, Rochefort H. Cathepsin D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocrinol Metab 1990;70:115-21.
37. Nazeer R, Malfetano JH, Rosano TG, Ross JS. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. Am J Clin Pathol 1992;97:764-9.
38. Crombach G, Ingenhorst A, Gohring U-J, Mobus V, Peters D, Schaeffer H-Jet, et al. Cathepsin D concentrations in the cytosol of benign and malignant tumors of the breast and the female genital tract. Tumordiagn u Ther 1992;13:14-18.